UnknownNot Applicable

Pulsed Electromagnetic Fields for Analgesia Post Mastectomy

Italy160 participantsStarted 2023-05-09

Plain-language summary

Study aim is to test AlgoCare, a device that uses the technology PEMF (Pulsed ElectroMagnetic Fields) for the treatment of postoperative pain in oncological breast surgery, in order to demonstrate that the use of Algocare in the postoperative period allows for a reduction in pain intensity in terms of Numerical Rating Scale (NRS) score and use of analgesic drugs.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Breast cancer patients undergoing unilateral mastectomy with reconstruction and without axillary dissection Exclusion Criteria: * Patients with PaceMakers (PMs), Implantable Cardioverter Defibrillators (ICDs), neurostimulators or other active medical devices or metal implants near the application area * Pregnancy * Amyloidosis, sarcoidosis, scleroderma, infectious arthritis, Paget's disease or joint tumors

What they're measuring

Pain intensity

Timeframe: 72 hours

Trial details

NCT IDNCT06331793

SponsorEuropean Institute of Oncology

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-12-31

Contact for this trial

Daniele Sances, MD

+390257489618 daniele.sances@ieo.it

View on ClinicalTrials.gov More Female Breast Cancer trials